(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.36%) $91.45
4 days till quarter result
(bmo 2024-05-08)
Expected move: +/- 0.00%
7.84% ¥ 1 251.00
Live Chart Being Loaded With Signals
Japan Lifeline Co., Ltd., a medical device company, develops, produces, imports, distributes, and trades in cardiovascular related medical devices in Japan...
Stats | |
---|---|
Volumen de hoy | 843 000 |
Volumen promedio | 196 158 |
Capitalización de mercado | 93.74B |
EPS | ¥0 ( 2024-02-01 ) |
Próxima fecha de ganancias | ( ¥0 ) 2024-05-08 |
Last Dividend | ¥38.00 ( 2023-03-30 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 12.67 |
ATR14 | ¥0.991 (0.08%) |
Volumen Correlación
Japan Lifeline Co., Ltd. Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Japan Lifeline Co., Ltd. Correlación - Moneda/Commodity
Japan Lifeline Co., Ltd. Finanzas
Annual | 2023 |
Ingresos: | ¥51.38B |
Beneficio Bruto: | ¥30.38B (59.12 %) |
EPS: | ¥98.72 |
FY | 2023 |
Ingresos: | ¥51.38B |
Beneficio Bruto: | ¥30.38B (59.12 %) |
EPS: | ¥98.72 |
FY | 2022 |
Ingresos: | ¥51.75B |
Beneficio Bruto: | ¥29.90B (57.77 %) |
EPS: | ¥88.22 |
FY | 2022 |
Ingresos: | ¥51.47B |
Beneficio Bruto: | ¥28.84B (56.02 %) |
EPS: | ¥93.13 |
Financial Reports:
No articles found.
Japan Lifeline Co., Ltd. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥0 (N/A) |
¥0 (N/A) |
¥38.00 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | ¥3.13 | 2000-03-28 |
Last Dividend | ¥38.00 | 2023-03-30 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 22 | -- |
Total Paid Out | ¥232.75 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.96 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 3.10 | |
Div. Directional Score | 7.47 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
8278.T | Ex Dividend Knight | 2024-02-28 | Semi-Annually | 0 | 0.00% | |
7640.T | Ex Dividend Junior | 2023-10-30 | Annually | 0 | 0.00% | |
6848.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
6197.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
4923.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
4093.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
3296.T | Ex Dividend Junior | 2023-12-28 | Semi-Annually | 0 | 0.00% | |
2374.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
9305.T | Ex Dividend Junior | 2023-09-28 | Annually | 0 | 0.00% | |
8035.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.146 | 1.500 | 7.07 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.102 | 1.200 | 6.59 | 7.91 | [0 - 0.3] |
returnOnEquityTTM | 0.133 | 1.500 | 9.63 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 3.02 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 1.831 | 0.800 | 3.94 | 3.15 | [0.8 - 2.5] |
cashRatioTTM | 0.894 | 1.500 | 6.15 | 9.22 | [0.2 - 2] |
debtRatioTTM | 0.0549 | -1.500 | 9.08 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 514.15 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 23.76 | 2.00 | 2.08 | 4.16 | [0 - 30] |
freeCashFlowPerShareTTM | 23.76 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.0695 | -1.500 | 9.72 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.591 | 1.000 | 3.48 | 3.48 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.200 | 1.000 | 8.00 | 8.00 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.442 | 1.000 | 8.66 | 8.66 | [0.2 - 2] |
assetTurnoverTTM | 0.699 | 0.800 | 8.67 | 6.94 | [0.5 - 2] |
Total Score | 11.85 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 12.49 | 1.000 | 8.84 | 0 | [1 - 100] |
returnOnEquityTTM | 0.133 | 2.50 | 9.76 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 23.76 | 2.00 | 2.08 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 3.36 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 23.76 | 2.00 | 2.08 | 4.16 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.0456 | 1.500 | -3.03 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0347 | 1.000 | -1.633 | 0 | [0.1 - 0.5] |
Total Score | 3.10 |
Japan Lifeline Co., Ltd.
Japan Lifeline Co., Ltd., a medical device company, develops, produces, imports, distributes, and trades in cardiovascular related medical devices in Japan. The company's cardiac rhythm management products include cardiac pacemakers, implantable cardioverter defibrillators, subcutaneous implantable cardioverter defibrillators, cardiac resynchronization therapy defibrillators and pacemakers, automated external defibrillators, and cardiopulmonary resuscitation support devices; and electrophysiology/ablation products comprise electrophysiological and ablation catheters, irrigated tip ablation catheters, endoscopic balloon ablation systems, esophageal temperature monitoring systems, internal atrial cardioversion systems, and radio-frequency transseptal needles. Its cardiovascular and endografting products consist of vascular and open stent grafts, and abdominal stent-grafts; and transvascular intervention products include PTCA and PTA guide wires, PTCA balloon catheters, radiofrequency wires, and atrial septal defect closure devices. The company offers gastrointestinal intervention products that consist of radiofrequency ablation systems, self-expandable colonic stents, and endoscopic guidewires. Japan Lifeline Co., Ltd. was incorporated in 1981 and is headquartered in Tokyo, Japan.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico